Kenox Pharmaceuticals (Princeton, NJ) is a specialty contract development, manufacturing, and testing organization focused on nasal, inhalation, and ophthalmic drug products. Kenox provides end-to-end support spanning early-stage research, formulation and analytical development, IVBE testing, compounding, fill-finish, and GMP clinical manufacturing, enabling seamless progression from concept through Phase I and II clinical supply.
Kenox’s expertise spans both non-sterile and sterile drug-device combination products, supporting quality, reliability, and regulatory alignment across a wide range of development programs. Our teams bring deep technical knowledge and broad industry experience in complex delivery platforms, including soft mist inhalers (SMIs), dry powder inhalers (DPIs), nebulizers, nasal sprays, and other advanced aerosol technologies. We support development programs involving small molecules, peptides, and biologics.
Purpose-built for OINDP development, Kenox combines scientific rigor with operational excellence to help accelerate timelines and reduce program risk. Through flexible, high-quality solutions and a collaborative approach, Kenox helps partners advance innovative drug delivery systems across North America and expanding global markets.
Kenox Pharmaceuticals
11 Deerpark Dr, Suite 128
Princeton Corporate Plaza
Monmouth Junction, NJ 08852
USA
+1 609 541 7357
www.kenoxpharma.us
bd@kenoxpharma.us
Specialized CDMO Services
Kenox Pharmaceuticals offers reliable, agile, and cost-efficient CDMO services for pharmaceutical and biotech companies developing inhalation, intranasal, and ocular therapies. Its integrated support helps advance treatments for local and systemic conditions through flexible development and manufacturing solutions tailored to program needs, timelines, regulatory requirements, clinical and later commercialization goals worldwide.
More Info
Molecule to Clinical Manufacturing
Kenox offers a fully Clinical Manufacturing Ready platform that expands its integrated OINDP capabilities through enhanced GMP analytical testing and IVBE services. Backed by end-to-end R&D, formulation, device and aerosol testing, fill-finish, and GMP release capabilities, Kenox advances sterile and non-sterile nasal and inhaled products to clinical supply.
More Info
Enhanced Testing Capabilities
Kenox offers expanded OINDP testing capabilities with Laser Diffraction and Spray VIEW systems for DSD, Spray Pattern, and Plume Geometry analysis. These GMP-compliant services strengthen its integrated CDMO platform, supporting aerosol performance characterization, regulatory submissions, bioequivalence studies, and lifecycle management with validated methodologies aligned to FDA and EMA expectations.
More Info
